期刊文献+

钆喷酸葡胺对比剂在临床中的不良反应分析 被引量:3

Analysis of Clinical Side-effect of Gadolinium Injection Acid Meglumine Contrast Agents
下载PDF
导出
摘要 目的通过对钆喷酸葡胺对比剂的不良反应进行探讨,以提高对其安全使用认识。方法对攀枝花市中心医院1880例静脉注射钆喷酸葡胺对比剂中发生不良反应的病例进行分类分析。结果钆喷酸葡胺对比剂发生不良反应15例(0.80%);其中轻度13例,重度2例。结论静脉注射钆喷酸葡胺对比剂的不良反应发生率低,但严重不良反应可危及生命,应引起临床重视。 Objective To improve the understanding of safe use of gadolinium injection acid meglumine contrast agents by analyzing its side-effect. Methods The side-effect of gadolinium injection acid meglumine contrast agents on 1880 patients between 2011 and 2014 in Panzhihua Central Hospital. Results Of these patients, 15 (0.80%) suffered from side effect, with 2 cases of severe side-effect. Conclusion The incidence of side-effect is very low after injection of intravenous gadolinium acid meglumine. Hhowever, severe side-effect could pose a risk to life, which should be a clinical concern.
出处 《解放军药学学报》 CAS CSCD 2015年第2期177-178,共2页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 钆喷酸葡胺对比剂 不良反应 安全性 gadolinium injection acid meglumine contrast medium side-effects security
  • 相关文献

参考文献3

二级参考文献24

  • 1许虹,任丽.钆喷酸葡胺MRI增强检查引起副反应5例报告[J].解放军护理杂志,2000,17(5):39-39. 被引量:11
  • 2任力杰,韩漫夫,雷益.钆喷酸葡胺对比剂的安全性再评价——附5例不良反应分析[J].罕少疾病杂志,2007,14(3):38-40. 被引量:13
  • 3Niendorf HP,Haustein J,Cornelius I,et al.Safety of gadolinium DTPA:extended clinical experience[J].Magn Reson Med,1991,22(2):222-228.
  • 4Jordan RM,Mintz RD.Fatal reaction to gadopentetate dime-glumine[J].AJR,1995,164(3):743-744.
  • 5Abujudeh HH,Kosaraju VK,Kaewlai R.Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine:experience with 32659 injections[J].AJR,2010,194(2):430-434.
  • 6Nelson KL,Gifford LM,Lauber-Huber C,et al.Clinical safety of gadopentetate dimeglumine[J].Radiology,1995,196(2):439-443.
  • 7Ridder F,Maeseneer M,Stadnik T,et al.Severe adverse reactions with contrast agents for magnetic resonance:clinical experience in 30,000 MR examinations[J].JBR-BTR,2001,84(4):150-152.
  • 8Kirchin MA,Pirovano G,Venetianer C,et al.Safety assessment of gadobenate dimeglumine (MultiHance):extended clinical experience from phase Ⅰstudies to post-marketing surveillance[J].JMRI,2001,14(3):281-294.
  • 9Herborn CU,Jager-Booth I,Lodemann KP,et al.Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)[J].Rofo,2009,181(7):652-657.
  • 10Petersein J,Spinazzi A,Giovagnoni A,et al.Focal liver lesions:evaluation of the efficacy of gadobenate dimeglumine in MR imaging a multicenter phase Ⅲ clinical study[J].Radiology,2000,215(3):727-736.

共引文献24

同被引文献55

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部